[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid

C33H40ClN5O7S — CID 118292665

IUPAC[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
SMILESCc1c(Cl)nc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)CS(C)(=O)=O)c2ccccc21
InChIInChI=1S/C33H40ClN5O7S/c1-19-22(21-12-8-9-13-23(21)35-29(19)34)17-38-24-14-10-11-15-25(24)39(27(40)18-47(7,45)46)20(2)28(31(38)42)36-30(41)26(16-33(3,4)5)37(6)32(43)44/h8-15,20,26,28H,16-18H2,1-7H3,(H,36,41)(H,43,44)/t20-,26-,28-/m0/s1
InChIKeyIXBXXESMDJEVBX-GHKAFPQUSA-N
MW686.23 g/mol
LogP4.41
Rot. Bonds8

About [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid

[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid (PubChem CID 118292665) has the molecular formula C33H40ClN5O7S and a molecular weight of 686.23 g/mol. Its IUPAC name is [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid.

Molecular Properties

Compound Name[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
PubChem CID118292665
Molecular FormulaC33H40ClN5O7S
Molecular Weight686.23 g/mol
Exact Mass685.23
IUPAC Name[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid
SMILESCc1c(Cl)nc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)CS(C)(=O)=O)c2ccccc21
InChIInChI=1S/C33H40ClN5O7S/c1-19-22(21-12-8-9-13-23(21)35-29(19)34)17-38-24-14-10-11-15-25(24)39(27(40)18-47(7,45)46)20(2)28(31(38)42)36-30(41)26(16-33(3,4)5)37(6)32(43)44/h8-15,20,26,28H,16-18H2,1-7H3,(H,36,41)(H,43,44)/t20-,26-,28-/m0/s1
InChIKeyIXBXXESMDJEVBX-GHKAFPQUSA-N
XLogP4.41
TPSA157.29 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms47
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500686.23
LogP ≤ 54.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The IUPAC name of [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid (CID 118292665) is [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid.
What is the SMILES notation for [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The canonical SMILES for [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid is Cc1c(Cl)nc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](CC(C)(C)C)N(C)C(=O)O)[C@H](C)N(C(=O)CS(C)(=O)=O)c2ccccc21.
What is the InChIKey of [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
The InChIKey is IXBXXESMDJEVBX-GHKAFPQUSA-N. The full InChI is InChI=1S/C33H40ClN5O7S/c1-19-22(21-12-8-9-13-23(21)35-29(19)34)17-38-24-14-10-11-15-25(24)39(27(40)18-47(7,45)46)20(2)28(31(38)42)36-30(41)26(16-33(3,4)5)37(6)32(43)44/h8-15,20,26,28H,16-18H2,1-7H3,(H,36,41)(H,43,44)/t20-,26-,28-/m0/s1.
What are the key properties of [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid?
[(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid has a molecular weight of 686.23 g/mol, XLogP of 4.41, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[[(3S,4S)-1-[(2-chloro-3-methylquinolin-4-yl)methyl]-4-methyl-5-(2-methylsulfonylacetyl)-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]-methylcarbamic acid is sourced from PubChem (CID 118292665), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).